These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10993853)

  • 41. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
    Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-year clinical follow-up after Palmaz-Schatz stenting.
    Klugherz BD; DeAngelo DL; Kim BK; Herrmann HC; Hirshfeld JW; Kolansky DM
    J Am Coll Cardiol; 1996 Apr; 27(5):1185-91. PubMed ID: 8609340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety, success, and restenosis after elective coronary implantation of the Palmaz-Schatz stent in 100 patients at a single center.
    Foley JB; Penn IM; Brown RI; Murray-Parsons N; White J; Galligan L; MacDonald C
    Am Heart J; 1993 Mar; 125(3):686-94. PubMed ID: 8438698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term (> 3 years) clinical and angiographic outcomes of coronary multilink stent implantations: a single center experience.
    Sonmez K; Turan F; Gencbay M; Degertekin M; Duran NE
    Angiology; 2004; 55(5):469-77. PubMed ID: 15378108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.
    Herrmann HC; Buchbinder M; Clemen MW; Fischman D; Goldberg S; Leon MB; Schatz RA; Tierstein P; Walker CM; Hirshfeld JW
    Circulation; 1992 Sep; 86(3):812-9. PubMed ID: 1516193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inter-series differences in the restenosis rate of Palmaz-Schatz coronary stent placement: differences in demographics and post-procedure lumen diameter.
    Carrozza JP; Kuntz RK; Schatz RA; Leon M; Goldberg S; Savage M; Fischman D; Senerchia C; Diver DJ; Baim DS
    Cathet Cardiovasc Diagn; 1994 Mar; 31(3):173-8. PubMed ID: 8025932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incomplete expansion of Palmaz-Schatz stents despite high-pressure implantation technique: impact on target lesion revascularization.
    Blessing E; Hausmann D; Sturm M; Wolpers HG; Amende I; Mügge A
    Cardiology; 1999; 91(2):102-8. PubMed ID: 10449881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Is Palmaz-Schatz stenting effective for second restenosis?].
    Kishi K; Hiasa Y; Suzuki N; Miyamoto H; Takahashi T; Hosokawa S; Tanimoto M; Otani R
    J Cardiol; 1999 Nov; 34(5):243-8. PubMed ID: 10579132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The short-term results and angiographic predictors of subacute thrombosis in the coronary implantation of the Palmaz-Schatz endoprosthesis].
    Díaz L; Fajadet J; Cassagneau B; Robert G; Marco J
    Rev Esp Cardiol; 1994 Nov; 47(11):747-53. PubMed ID: 7800905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial).
    Russo RJ; Silva PD; Teirstein PS; Attubato MJ; Davidson CJ; DeFranco AC; Fitzgerald PJ; Goldberg SL; Hermiller JB; Leon MB; Ling FS; Lucisano JE; Schatz RA; Wong SC; Weissman NJ; Zientek DM;
    Circ Cardiovasc Interv; 2009 Apr; 2(2):113-23. PubMed ID: 20031704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcome of intracoronary microstent implantation: lesion matched comparison with Palmaz-Schatz stent.
    Agarwal R; Bhargava B; Kaul U; Rao MB; Behl VK; Talwar KK; Manchanda SC
    Cathet Cardiovasc Diagn; 1998 Apr; 43(4):397-401. PubMed ID: 9554763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
    Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
    Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoperfusion balloon versus stent for acute or threatened closure during percutaneous transluminal coronary angioplasty.
    de Muinck ED; den Heijer P; van Dijk RB; Crijns HJ; Hillege HJ; Twisk SP; Lie KI
    Am J Cardiol; 1994 Nov; 74(10):1002-5. PubMed ID: 7977036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.
    Cohen DJ; Krumholz HM; Sukin CA; Ho KK; Siegrist RB; Cleman M; Heuser RR; Brinker JA; Moses JW; Savage MP
    Circulation; 1995 Nov; 92(9):2480-7. PubMed ID: 7586348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
    Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
    Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Restenosis after the implantation of Palmaz-Schatz vascular stents in the coronary arteries].
    Haude M; Issa H; Herber M; Meyer J; Erbel R
    Dtsch Med Wochenschr; 1993 Sep; 118(38):1349-54. PubMed ID: 8404475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients.
    Kastrati A; Dirschinger J; Boekstegers P; Elezi S; Schühlen H; Pache J; Steinbeck G; Schmitt C; Ulm K; Neumann FJ; Schömig A
    Catheter Cardiovasc Interv; 2000 Jul; 50(3):290-7. PubMed ID: 10878624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study.
    Serruys PW; Emanuelsson H; van der Giessen W; Lunn AC; Kiemeney F; Macaya C; Rutsch W; Heyndrickx G; Suryapranata H; Legrand V; Goy JJ; Materne P; Bonnier H; Morice MC; Fajadet J; Belardi J; Colombo A; Garcia E; Ruygrok P; de Jaegere P; Morel MA
    Circulation; 1996 Feb; 93(3):412-22. PubMed ID: 8565157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.